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Abstract
Background and purpose Delirium is a very common neurobehavioral complication after stroke, but its influence on long-
term outcome is not well characterized. The objective of the study was to determine the prognostic significance of delirium 
for functional status, nursing home admission, and mortality in a large cohort of patients with delirium in the acute phase 
of stroke assessed 3 and 12 months after stroke.
Methods All stroke survivors included in PROPOLIS were followed up (n = 682). Outcome data included: discharge des-
tination, recurrence of stroke, cardiovascular complications, functional activity and mobility, nursing home admission, and 
mortality.
Results Patients with delirium were discharged to another hospital or nursing home significantly more often than those 
presenting without delirium. The 3- and 12-month post-stroke mortality rates were higher in delirious patients (OR 6.41 CI 
3.76–10.92; p < 0.001 and OR 5.17 CI 3.36–7.96; p < 0.001). When considering 3-month mortality, higher age, modified 
Rankin Scale prior to admission and temperature between 1 and 3 days after admission, as well delirium, pneumonia and 
more severe neurological deficits on admission were independent risk factors. For 12-month mortality, the independent risk 
factors were higher age and modified Rankin Scale post-stroke, delirium, and history of respiratory diseases prior to stroke. 
Patients with delirium were more likely to live in nursing homes 3 and 12 months after stroke and were more disabled than 
patients without delirium.
Conclusions Delirium in acute phase of stroke negatively influences the long-term prognosis. A study addressing the effect 
of early recognition and treatment of identified modifiable risk factors for adverse long-term outcomes is urgently needed 
to decrease bad prognosis within this population.
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Introduction
Delirium is a common complication of stroke, with the fre-
quency estimated to be between 10 and 48% [1]. There is 
abundant data linking delirium to adverse clinical outcomes 
in medical and surgical geriatric populations; however, post-
stroke delirium remains understudied with little known about 
its effect on clinical outcome and long-term prognosis. Addi-
tionally, the limited available studies on long-term prognosis 
for patients with delirium in the acute phase of stroke show 
inconsistent data regarding long-term life expectancy [2–8].
Long-term medical consequences for both delirious 
patients and healthcare budgets are serious. Considering 
the inconsistent data from previous studies and the lack 
of data on the outcome of delirium in the acute phase of 
stroke in the Polish population, the aim of this single-center 
PRospective Observational POLIsh Study on post-stroke 
delirium (PROPOLIS) was to determine the prognostic sig-
nificance of delirium for discharge destination, recurrence 
of stroke, cardiovascular events, functional status, nursing 
home admission, and death. This was assessed by following 
a large cohort of patients with stroke for 12 months.
Materials and methods
Population and design
A total of 750 consecutive patients admitted to the Stroke 
Unit at the University Hospital in Krakow between June 
2014 and March 2016, presenting with stroke (ischemic or 
hemorrhagic) or transient ischemic attack, and meeting the 
inclusion criteria for this study (patients over 18 years of 
age, admitted within 48 h from the first stroke symptoms, 
speaking Polish) were included in the assessment [9]. Fig-
ure 1 shows the study procedures.
Patients were screened for delirium every day from 
admission to the 7th day of hospitalization with the abbre-
viated version of Confusion Assessment Method (bCAM). 
In those with motor aphasia, or those who could not com-
municate for other reasons, the Intensive Care Units version 
(CAM-ICU) [10, 11] was adopted. To assess the severity 
of delirium symptoms, the Delirium Rating Scale Revised 
98 [12] and Cognitive Test for Delirium [13] were applied.
A resident neurologist specially trained in delirium 
diagnosis was responsible for screening for delirium, 
and a trained psychologist was responsible for cognitive 
assessment. The senior neurologist/neuropsychologist was 
responsible for evaluating all data. The physicians rating the 
patients did not change during the study.
To obtain information for possible delirious symptoms 
during the first 24 h, a short questionnaire regarding patients’ 
behavior and cognitive fluctuations, was completed by ward 
nurses for each patient.
Diagnosis of delirium was based on clinical observation 
and structural assessment. The final diagnosis of delirium 
was based on DSM-5 [14]. For those patients who were 
not able to undergo cognitive evaluation, the diagnosis 
was based on clinical observation and DSM-5 criteria for 
delirium.
Data were collected regarding socio-demographic fac-
tors, smoking (current, ex-smoker, and never smoked), and 
comorbidities (hypertension, diabetes mellitus, atrial fibril-
lation, myocardial infarct, percutaneous coronary interven-
tion, coronary artery bypass grafting, respiratory system 
disorders, gastrointestinal complications, liver and renal dys-
functions, genitourinary problems, past neurological history, 
musculoskeletal dysfunctions, and endocrine problems). The 
Cumulative Illness Rating Scale (CIRS) was used as a gen-
eral indicator of health status [15]. To screen for pre-stroke 
dementia Polish version of Informant Questionnaire on Cog-
nitive Decline in the Elderly (IQCODE) was used [16].
Both cognitive and behavior/emotional functioning were 
also assessed during hospital stay. For cognitive assessment, 
the Montreal Cognitive Assessment (MoCA) [17], Frontal 
Assessment Battery [18], and Cognitive Test for Delirium 
[13] were used between first–second day and on 7th day 
after admission. On admission, information was obtained 
from the spouse/caregiver regarding pre-stroke behavioral 
functioning on Neuropsychiatric Inventory [19].
All patients had neuroimaging (CT/MRI) performed at 
admission. The severity of clinical deficit was graded by the 
National Institutes of Health Stroke Scale (NIHSS) [20], also 
upon admission. Disability prior to admission was assessed 
by the modified Rankin Scale (mRS) [21]. Details of data 
acquisition and patients characteristics are described else-
where [9].
Outcome assessment
All patients dismissed from the hospital were scheduled for a 
follow-up visit 3 and 12 months after their stroke. Outcome 
assessment included discharge destination (home, rehabilita-
tion hospital, long-term institution), occurrence of a vascular 
event (heart attack, any heart surgery, cardioversion, and 
endarterectomy), dependence (mRS), or death. Information 
regarding recurrence of stroke or TIA, pneumonia [22], 
place of stay (patient’s own home, hospital, nursing home), 
and the level of activities of daily leaving (I.A.D.L.) [23] 
was also collected.
Patients who did not attend a follow-up visit were con-
tacted by phone. If the patient could not be interviewed, a 
next-of-kin was contacted and information was gathered. 
Mortality data were collected when a researcher was reliably 
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informed of the death of a participant, usually by a close 
informant of their household.
The medical ethical committee of the Jagiellonian Uni-
versity approved the study. Informed written consent was 
provided by the patient or a caregiver.
Statistics
All of the statistical analyses were calculated using STATIS-
TICA for Windows version 12 (StatSoft Inc., Tulsa, Okla-
homa). First, descriptive statistics were performed to obtain 
information about the group. Associations between 3-month 
and 12-month mortality and predisposing factors were 
found and p values were obtained using univariate logis-
tic regression (Table 1). Variables significantly associated 
with delirium according to the univariate logistic regres-
sion were then entered into multivariable logistic regression 
analysis. Best fitted 3-month and 12-month mortality mod-
els were obtained using forward stepwise selection method. 
Final model included age and was then adjusted for sex and 
comorbidities (CIRS score). Kaplan–Meier curves were 
used to present 3-month and 12-month survival according 
to post-stroke delirium incidence. Gehan’s Wilcoxon tests 
were used to compare mortality in these groups. At the end, 
other outcome data were compared—categorical variables 
(stroke recurrence, cardiovascular complications, and dis-
charge destination) according to delirium incidence using 
Chi-squared test and quantitative variables (mRS, IADL) 
using Mann–Whitney test. The value of α = 0.05 was con-
sidered as a threshold for statistical significance.
Fig. 1  Flowchart of the study procedures
2713Journal of Neurology (2019) 266:2710–2717 
1 3
Table 1  Baseline characteristic of studied population
Delirium Rating Scale Revised 98, Cognitive Test for Delirium IQCODE Informant Questionnaire on Cognitive Decline in the Elderly, mRS 









mean (SD) count 
(%)
Mortality 3 months post-
stroke (univariate analysis 
p value)
Mortality 12 months post-
stroke (univariate analysis 
p value)
Total 750
Delirium 203 (27%) 547 (73%) < 0.001 < 0.001
 Mean CTD 136 11.2 (5.9) 11.2 (5.9) – 0006 < 0.001
 Mean DRS 203 18.2 (4.5) 18.2 (4.5) – < 0.001 < 0.001
 Duration time 203 4.2 (2.3) 4.2 (2.3) – > 0.05 0.044
Mean age (SD), years 750 71.8 (13.1) 77.0 (10.7) 69.8 (13.4) < 0.001 < 0.001
Hemorrhagic stroke 750 52 (7%) 24 (12%) 28 (5%) > 0.05 > 0.05
Ischemic stroke 750 650 (87%) 170 (84%) 480 (88%) > 0.05 > 0.05
TIA 750 48 (6%) 9 (4%) 39 (7%) > 0.05 > 0.05
Gender (male) (%) 750 352 (47%) 84 (41%) 268 (49%) > 0.05 > 0.05
Cerebellar stroke vs hemi-
spherical/brainstem
735 73 (10%) 8 (4%) 65 (12%) > 0.05 > 0.05
Left vs. right hemisphere 661 364 (55%) 91 (45%) 273 (50%) > 0.05 > 0.05
Education (SD), years 658 11.4 (3.3) 10.5 (3.1) 11.7 (3.4) > 0.05 0.045
IQCODE (SD) 610 83.3 (11.5) 86.8 (15.5) 82.0 (9.1) < 0.001 < 0.001
The Montreal Cognitive 
Assessment
511 19.3 (6.8) 11.4 (6.5) 21.0 (5.5) < 0.001 < 0.001
Hypertension 747 533 (71%) 145 (71%) 388 (71%) > 0.05 > 0.05
Diabetes mellitus 747 203 (27%) 71 (35%) 132 (24%) > 0.05 > 0.05
Atrial fibrillation 748 180 (24%) 76 (37%) 104 (19%) 0.014 < 0.001
Myocardial infarct 747 106 (14%) 33 (16%) 73 (13%) > 005 > 0.05
Respiratory diseases 
(0–4)
747 1.0 (1.1) 1.2 (1.3) 0,.9 (1.0) 0.004 < 0.001
CIRS
 Total Score 747 9.4 (4.9) 11.0 (4.7) 8.8 (4.9) < 0.001 < 0.001
 Severity index 747 0.7 (0.4) 0.8 (0.4) 0.6 (0.4) < 0.001 < 0.001
 Comorbidity Index 747 3.5 (1.9) 4.2 (1.8) 3.3 (1.9) < 0.001 < 0.001
Pneumonia at admission 750 72 (10%) 41 (20%) 31 (6%) < 0.001 < 0.001
Pneumonia during hospi-
talization
750 44 (6%) 23 (11%) 21 (4%) 0.039 < 0.001
Urinary tract infection at 
admission
723 207 (29%) 85 (42%) 122 (22%) 0.001 < 0.001
Urinary tract infection 
during hospitalization
723 44 (6%) 13 (6%) 31 (6%) > 0.05 > 0.05
Hospitalization (days) 750 11.1 (7.3) 14.0 (10.6) 10.0 (5.3) > 0.05 < 0.001
Aphasia 750 255 (34%) 89 (44%) 166 (30%) < 0.001 < 0.001
Neglect 750 94 (13%) 62 (31%) 32 (6%) 0.038 > 0.05
Vision deficits 750 298 (40%) 145 (71%) 153 (18%) < 0.001 < 0.001
NIHSS 750 8.5 (7.3) 13.0 (6.7) 6.9 (6.8) < 0.001 < 0.001
Pre-stroke modified 
Rankin Scale
749 0.7 (1.4) 1.3 (1.7) 0.5 (1.2) < 0.001 < 0.001
mRS (7–10 day after 
admission)
750 2.6 (2.0) 4.1 (1.6) 2.1 (1.9) < 0.001 < 0.001
Maximal temperature 
between 1 and 3 day
750 37.1 (0.7) 37.4 (0.7) 37.1 (0.7) < 0.001 < 0.001
Maximal temperature 
between 4 and 7 day
726 37.0 (0.7) 37.2 (0.7) 36.9 (0.6) < 0.001 < 0.001
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Results
Of the 750 patients included 682 stroke survivors were 
scheduled for follow-up visits (a flow chart shows the 
study design). From them, 67 died and 43 were lost from 
the follow-up 3 months post-stroke. Ultimately, patients 
with delirium in the acute phase of stroke experienced 
increased mortality within 3 months post-stroke (26.62% 
vs. 5.36%, Person’s χ2 56.302 p < 0.001; survival compari-
son shown in Fig. 2—Gehan’s Wilcoxon test p < 0.001). 
The baseline characteristic of the stroke population and 
risk factors for death after 3 months are shown in Table 1. 
Patients who died were also significantly older, had more 
sever delirium and cognitive impairment prior to and dur-
ing hospital stay, had more sever concomitant chronic dis-
eases (in particular atrial fibrillation and diseases affecting 
respiratory tract) and higher temperature between days 1 
and 7 of hospitalization. Death was also significantly more 
common in those with aphasia, neglect and vision deficit 
and in those more disabled on admission and on discharge.
Delirium was found to be an independent risk factor for 
death in univariate logistic regression analysis (OR 6.41 
CI 3.76–10.92; p < 0.001). In the multivariable logistic 
regression model, delirium remained significantly asso-
ciated with mortality 3 months after stroke (results are 
shown in Table 2).
Twelve months after their strokes, 485 patients attended 
follow-up visits (52 died and 35 were lost from the follow-
up). Mortality 12 months post-stroke was higher in those 
with delirium (42.66% vs. 12.58%, Person’s χ2 62.406; 
p < 0.001; survival comparison shown in Fig. 2—Gehan’s 
Wilcoxon test p < 0.001). Patients who died were also 
older, had more severe delirium and cognitive impairment 
prior to and during hospital stay, were less educated, had 
longer hospitalization, more severe concomitant chronic 
diseases (in particular atrial fibrillation and diseases 
affecting respiratory tract) and higher temperature between 
1 and 7 day of hospitalization. Death was also more often 
in those with aphasia, vision deficit and in those more 
disabled on admission and on discharge.
Delirium was found to be an independent risk factor for 
12 months mortality in univariate logistic regression anal-
ysis (OR 5.17 CI 3.36–7.96; p < 0.001). In multivariable 
logistic regression model, delirium remained significantly 
associated with 12-months post-stroke mortality (results 
are shown in Table 2).
Patients with delirium were also more disabled and 
reported a larger impairment on daily activities than those 
without delirium 3 and 12 months post stroke (Table 3 
shows these results).
Three months post stroke, patients with delirium were 
less often at home and were more often hospitalized or 
placed in a nursing home compared to patients without 
delirium (47.32; 33.04; 19,64% vs. 74.56; 22.81; 2.63%, 
respectively). The Chi-square test was highly significant 
(p < 0.001).
The results regarding living situations were consist-
ent in the second follow-up meeting. Twelve months post 
stroke, patients with delirium were at home or hospital-
ized less often, and were placed more often in nursing 
home than patients without delirium (64.56; 0.00; 35.44% 
vs. 93.29; 0.48; 6.24%, respectively). The Chi-square 
test was highly significant (p < 0.001). In multivariable 
logistic regression model adjusted for NIHSS, CIRS, pre-
mRS, age, delirium remained significantly associated with 
higher disability and impairment on daily activities at 3 
and 12-months post-stroke (Supplementary materials).
We did not find a significant association between delir-
ium and recurrence of stroke or cardiovascular complica-
tions 3 and 12 months after stroke.
Discussion
The results of this study showed that delirium is inde-
pendently associated with a poorer prognosis both 3 and 
12 months after stroke, including greater functional dis-
ability, higher rates of admission to long-term institution-
alized facilities, and greater mortality, when compared to 
delirium-free patients.
This study identified a number of risk factors for post-
stroke mortality. Within these factors, increased tempera-
ture in acute phase of stroke and delirium were the only 
modifiable risk factors.
Our study confirmed some but not all of previously 
reported results. In a study by Dostovic et  al. [4] that 
Fig. 2  Kaplan–Meier curve demonstrating the cumulative mortal-
ity rate of patients with and without post-stroke delirium 3 and 
12 months following discharge
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followed 100 patients with delirium and 100 controls 
with stroke, delirious patients had a significantly higher 
mortality and a greater degree of functional disability in 
the first year after ischemic stroke. Sheng et al. [2] fol-
lowed 140 patients with stroke and found that delirium 
predicted 6 and 12  months mortality, disability and 
institutionalization. Both Henon et al. [6], who followed 
202 patients with stroke, and McManus et al. [5], who 
recruited 82 patients, did not find increased mortality at 6 
and 12 months, respectively. Miu et al. [3] included 314 
patients with stroke and followed them for 1 year. This 
study found that patients with delirium had more func-
tional disability and more often were placed in nursing 
homes at discharge. Mortality 6 and 12 months after stroke 
was higher in patients with delirium but the differences 
were not significant. Oldenbeuving et al. [7] who followed 
527 patients with stroke found that delirium was associ-
ated with lower functional outcome and higher mortal-
ity 1-month post stroke. Qu et al. [8] who observed 261 
patients with ischemic stroke for 6 months found that 
delirium was associated with worse functional outcome 
after 3 months.
Stroke patients often suffer from temperature elevations 
without an identifiable infection; possibly endogenous fever 
due to direct stroke effects on the brain [24]. We identified 
that increased temperature between first and third-day of the 
hospital stay independently increased mortality 3 months 
after stroke. The data about temperature management in acute 
Table 2  Independent risk factors for mortality 3 and 12 months post-stroke in multivariable logistic regression analysis
mRS modified Rankin Scale, NIHSS National Institute of Health Stroke Scale, CIRS The Cumulative Illness Rating Scale
*Adjusted for sex and comorbidities (CIRS scale)
3-Months mortality OR (CI) p OR (CI) adjusted* p
Age 1.05 (1.02–1.08) 0.002 1.06 (1.02–1.09) 0.003
Pre-mRS 1.65 (1.37–1.99) < 0.001 1.64 (1.35–1.99) < 0.001
Delirium 2.90 (1.58–5.31) 0.001 2.83 (1.54–5.21) 0.001
Pneumonia on admission 2.47 (1.13–5.39) 0.023 2.23 (0.98–5.10) 0.057
NIHSS on admission 1.05 (1.01–1.10) 0.027 1.05 (1.01–1.10) 0.025
Maximal temperature between 1 and 
3 day
1.59 (1.02–2.47) 0.042 1.58 (1.01–2.47) 0.043
Sex – – 1.63 (0.85–3.15) 0.143
CIRS – – 1.02 (0.96–1.09) 0.670
12-Months mortality OR (CI) p OR (CI) adjusted* p
Age 1.09 (1.06–1.12) < 0.001 1.09 (1.06–1.13) < 0.001
Delirium 1.75 (1.03–2.97) 0.038 1.72 (1.01–2.92) 0.044
Respiratory diseases 1.54 (1.22–1.93) < 0.001 1.45 (1.14–1.84) 0.003
mRS between 7 and 10 day 1.89 (1.60–2.24) < 0.001 1.91 (1.61–2.28) < 0.001
Sex – – 1.61 (0.92–2.84) 0.098
CIRS – – 1.02 (0.97–1.08) 0.397
Table 3  Functional impairment in patients with and without post-stroke delirium 3 and 12 months after stroke
mRS modified Rankin Scale, IADL Instrumental Activities of Daily Leaving
3-Months post-stroke Patients without delirium Patients with delirium p
median IQR median IQR
mRS 1 3 4 2 < 0.001
IADL 10 10 27 12 < 0.001
12-Months post-stroke Patients without delirium Patients with delirium p
Median IQR Median IQR
mRS 1 2 3 3 < 0.001
IADL 9 9 27 15 < 0.001
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stroke are inconclusive [25]. Our data provide support for tri-
als testing temperature lowering in acute phase of stroke as a 
preventing strategy for unfavorable long-term outcome.
Results of our study confirm the evidence from medi-
cal literature that delirium predicts a poor outcome [26]. 
Previous studies on the long-term outcome of post-stroke 
delirium were conducted on small cohorts. The large num-
ber of consecutive patients with stroke is a strength of our 
study—there is no other prospective study on post-stroke 
delirium with such a big cohort. The other strength of our 
study was the constant observation of patients by medical 
personnel and careful, formal assessment of delirium con-
ducted every day. For delirium screening we used bCAM 
for verbal patients or CAM-ICU for patients who could not 
speak but were able to communicate in a non-verbal way. 
Both methods have high sensitivity and specificity and are 
easy to administer [10, 11]. The same assessor administered 
the scale from day 1 to day 7, thus making the bias of inter-
observer variation minimal. All this allowed for the identifi-
cation of all delirium cases, even those lasting briefly.
This study included patients of a wide age rage. Enroll-
ment of younger patients might decrease the percentage of 
cases with post-stroke delirium. However, the mean age 
of the cohort was high and similar to other studies, there-
fore, we do not think that including younger patients would 
cause a bias. The number of patients lost from follow-up 
was small.
A limitation of our study is that the incidence of delir-
ium in the acute phase of stroke in our sample might be 
underestimated due to an observation period restricted to 
only 7 days. This is the median duration of hospital-stay in 
Krakow’s stroke unit. Therefore, those with delayed onset 
delirium were missed.
Conclusions
Delirium is a common complication of stroke and its long-
term consequences are very serious. Predisposing factors 
for its development were previously identified for the Pol-
ish population [7]. Unfavorable outcomes of patients with 
delirium in the acute phase of stroke emphasize the need 
of better awareness of this common stroke complication. 
As a matter of its course, data shows delirium is strongly 
associated with additional healthcare costs [27]. Bearing 
this in mind, results of our study support the need for fur-
ther studies addressing the influence of early recognition 
and treatment of delirium in the acute phase of stroke as 
well as testing lowering temperature to decrease later post-
stroke mortality and to decrease adverse long-term outcomes 
within this population, also to better appraise the associated 
healthcare burden.
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